Annual Short Term Debt
$83.60 K
+$4700.00+5.96%
31 December 2023
Summary:
Processa Pharmaceuticals annual short term debt is currently $83.60 thousand, with the most recent change of +$4700.00 (+5.96%) on 31 December 2023. During the last 3 years, it has fallen by -$121.20 thousand (-59.18%). PCSA annual short term debt is now -96.59% below its all-time high of $2.45 million, reached on 31 December 2017.PCSA Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$94.70 K
+$1500.00+1.61%
30 September 2024
Summary:
Processa Pharmaceuticals quarterly short term debt is currently $94.70 thousand, with the most recent change of +$1500.00 (+1.61%) on 30 September 2024. Over the past year, it has increased by +$12.00 thousand (+14.51%). PCSA quarterly short term debt is now -96.19% below its all-time high of $2.48 million, reached on 31 March 2018.PCSA Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PCSA Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +6.0% | +14.5% |
| 3 y3 years | -59.2% | +2.0% |
| 5 y5 years | -63.6% | +22.4% |
PCSA Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -59.2% | +17.6% | at high | +256.0% |
| 5 y | 5 years | -90.5% | +17.6% | -94.2% | +256.0% |
| alltime | all time | -96.6% | +17.6% | -96.2% |
Processa Pharmaceuticals Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $94.70 K(+1.6%) |
| June 2024 | - | $93.20 K(+3.9%) |
| Mar 2024 | - | $89.70 K(+7.3%) |
| Dec 2023 | $83.60 K(+6.0%) | $83.60 K(+1.1%) |
| Sept 2023 | - | $82.70 K(+1.0%) |
| June 2023 | - | $81.90 K(+0.9%) |
| Mar 2023 | - | $81.20 K(+2.9%) |
| Dec 2022 | $78.90 K(+11.0%) | $78.90 K(+3.4%) |
| Sept 2022 | - | $76.30 K(+186.8%) |
| June 2022 | - | $26.60 K(-45.8%) |
| Mar 2022 | - | $49.10 K(-30.9%) |
| Dec 2021 | $71.10 K(-65.3%) | $71.10 K(-23.4%) |
| Sept 2021 | - | $92.80 K(+0.4%) |
| June 2021 | - | $92.40 K(-61.8%) |
| Mar 2021 | - | $242.20 K(+18.3%) |
| Dec 2020 | $204.80 K(-76.7%) | $204.80 K(-87.5%) |
| Sept 2020 | - | $1.63 M(+12.7%) |
| June 2020 | - | $1.45 M(+64.3%) |
| Mar 2020 | - | $881.60 K(+0.1%) |
| Dec 2019 | $880.50 K(+282.8%) | $880.50 K(+1037.6%) |
| Sept 2019 | - | $77.40 K(-74.8%) |
| June 2019 | - | $307.50 K(+6.6%) |
| Mar 2019 | - | $288.50 K(+25.4%) |
| Dec 2018 | $230.00 K | $230.00 K(+1.0%) |
| Sept 2018 | - | $227.80 K(+1.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2018 | - | $224.10 K(-91.0%) |
| Mar 2018 | - | $2.48 M(+1.5%) |
| Dec 2017 | $2.45 M(+51.9%) | $2.45 M(>+9900.0%) |
| Sept 2017 | - | $0.00(-100.0%) |
| June 2017 | - | $1.69 M(+4.7%) |
| Mar 2017 | - | $1.61 M(0.0%) |
| Dec 2016 | $1.61 M(+18.0%) | $1.61 M(0.0%) |
| Sept 2016 | - | $1.61 M(0.0%) |
| June 2016 | - | $1.61 M(+16.6%) |
| Mar 2016 | - | $1.38 M(+1.2%) |
| Dec 2015 | $1.37 M(+1686.1%) | $1.37 M(-16.0%) |
| Sept 2015 | - | $1.63 M(+2.6%) |
| June 2015 | - | $1.59 M(+22.7%) |
| Mar 2015 | - | $1.29 M(+1588.4%) |
| Dec 2014 | $76.50 K(-87.9%) | $76.50 K(-85.7%) |
| Sept 2014 | - | $534.70 K(+81.7%) |
| June 2014 | - | $294.30 K(-45.7%) |
| Mar 2014 | - | $541.60 K(-14.2%) |
| Dec 2013 | $631.20 K(+19.7%) | $631.20 K(-39.3%) |
| Sept 2013 | - | $1.04 M(-48.4%) |
| June 2013 | - | $2.02 M(+159.5%) |
| Mar 2013 | - | $777.40 K(+47.5%) |
| Dec 2012 | $527.20 K(+75.7%) | $527.20 K(+1852.6%) |
| Sept 2012 | - | $27.00 K |
| Dec 2011 | $300.00 K | - |
FAQ
- What is Processa Pharmaceuticals annual short term debt?
- What is the all time high annual short term debt for Processa Pharmaceuticals?
- What is Processa Pharmaceuticals annual short term debt year-on-year change?
- What is Processa Pharmaceuticals quarterly short term debt?
- What is the all time high quarterly short term debt for Processa Pharmaceuticals?
- What is Processa Pharmaceuticals quarterly short term debt year-on-year change?
What is Processa Pharmaceuticals annual short term debt?
The current annual short term debt of PCSA is $83.60 K
What is the all time high annual short term debt for Processa Pharmaceuticals?
Processa Pharmaceuticals all-time high annual short term debt is $2.45 M
What is Processa Pharmaceuticals annual short term debt year-on-year change?
Over the past year, PCSA annual short term debt has changed by +$4700.00 (+5.96%)
What is Processa Pharmaceuticals quarterly short term debt?
The current quarterly short term debt of PCSA is $94.70 K
What is the all time high quarterly short term debt for Processa Pharmaceuticals?
Processa Pharmaceuticals all-time high quarterly short term debt is $2.48 M
What is Processa Pharmaceuticals quarterly short term debt year-on-year change?
Over the past year, PCSA quarterly short term debt has changed by +$12.00 K (+14.51%)